Publication | Closed Access
Preclinical Study of AUY922, a Novel Hsp90 Inhibitor, in the Treatment of Esophageal Adenocarcinoma
12
Citations
35
References
2015
Year
AUY922 exhibits antitumor efficacy in vitro and in vivo for EAC, suggesting the need for human clinical trials.
| Year | Citations | |
|---|---|---|
Page 1
Page 1